
Sign up to save your podcasts
Or


Gilead Sciences buys Kite Pharma for $12 billion in cash. Kristine Harjes and Jason Moser analyze the deal and what it means for Gilead’s future. Plus, Uber gets a new CEO (courtesy of Expedia), Fitbit rolls out a new smartwatch, and Whole Foods is now selling....Amazon Echo speakers.
By The Motley Fool4.7
16041,604 ratings
Gilead Sciences buys Kite Pharma for $12 billion in cash. Kristine Harjes and Jason Moser analyze the deal and what it means for Gilead’s future. Plus, Uber gets a new CEO (courtesy of Expedia), Fitbit rolls out a new smartwatch, and Whole Foods is now selling....Amazon Echo speakers.

3,216 Listeners

1,489 Listeners

807 Listeners

946 Listeners

524 Listeners

1,166 Listeners

2,182 Listeners

825 Listeners

1,421 Listeners

1,038 Listeners

9,717 Listeners

196 Listeners

827 Listeners

87 Listeners

589 Listeners

1,031 Listeners

53 Listeners